· Investment Strategies · 2 sources
Fundly.ai’s ~$4.9M: Accel and Multiply Expand India Pharma Commerce Rails
Mumbai’s Fundly.ai raised ~$4M equity led by Accel and Multiply Ventures plus ~$0.9M venture debt (~$4.9M) — doubling down after a 2023 $3M seed as it stacks B2B commerce, payments, and credit for pharma distribution.
Editorial team
Accel and Multiply Ventures led roughly $4 million of new equity into Mumbai’s Fundly.ai on September 8, 2026, with former RBL Bank executive director Rajeev Ahuja and other angels — plus about $0.9 million venture debt, for ~$4.9 million combined (Indian Startup Times). The print follows Accel’s $3 million 2023 seed.
Spine: India pharma distribution still runs on fragmented ordering and working capital — Fundly is trying to own the commerce + payments + credit stack for the same retailers Accel already underwrote once.
Key facts
- Founders
- Amit Chawla, Shreeram Ramanathan (2021)
- Structure
- ~$4M equity + ~$0.9M venture debt ≈ ~$4.9M
- Leads
- Accel, Multiply Ventures (existing)
- Prior
- $3M seed (2023, Accel-led)
- Use of proceeds
- Expand digital commerce, payments, and credit across pharma supply chain
- Valuation / ARR
- Not disclosed
Who uses the product — and for what job
Users: pharma retailers and distributors that procure stock, settle invoices, and need short-duration working capital.
Job: collapse three vendors (ordering portal, payments rail, lender) into one platform so daily inventory turns are not blocked by credit or reconciliation lag.
Fundly began as supply-chain finance and broadened — the raise funds that full-stack pitch, not a pure lender expansion alone.
Why Accel and Multiply — fit
Accel’s second cheque signals category conviction in vertical fintech rails where distribution density matters more than consumer brand spend. Multiply’s repeat participation reinforces India SMB/credit adjacency. Do not treat Accel as a linked /fund/ page — it is absent from our directory.
Debt alongside equity is a tell: growth that needs balance-sheet capacity for credit books, not only SaaS burn.
What is not proven
- GMV, take rate, NPL, and retailer count were not disclosed in the IST coverage reviewed.
- Round stage labeling is inferred (post-seed follow-on); company did not publish a Series letter in the piece cited.
- Venture-debt terms (lender, covenants) were not named.
Implication
Fundly’s next diligence gate is credit performance through the cycle, not feature breadth. If embedded loans stay clean while commerce volume rises, Accel’s double-down looks cheap; if credit losses climb, the $0.9M debt facility becomes the story.
Follow Venture Capital Tracker on Google
Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.